<DOC>
	<DOCNO>NCT01122030</DOCNO>
	<brief_summary>Study consist 6 treatment cohort 12 subject chronic pain , opioid-induced bowel dysfunction , opioid physical dependence . Total duration treatment subject 28 day . Each subject receive single dose study drug , administer orally morning Day 15 fast condition . Cohort 1 : 0.1 mg S-297995 placebo . Cohort 2 : 0.3 mg S-297995 placebo . Cohort 3 : 1 mg S-297995 placebo . Cohort 4 : 3 mg S-297995 placebo . Cohort 5 : 0.03 mg S-297995 placebo . Cohort 6 : 0.01 mg S-297995 placebo . The primary objective study evaluate safety single dose oral S-297995 subject physically dependent opioids</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy S-297995 Treatment Opioid-Induced Bowel Dysfunction Subjects With Chronic Pain</brief_title>
	<detailed_description>A single dose S-297995 matching placebo administer orally cohort 12 subject ( 9 treatment , 3 placebo ) morning Day 15 fast condition . The first cohort receive 0.1 mg dose . Cohorts continue enrol next high dose level high dose level ( 3 mg ) achieve study discontinue due adverse event Clinical Opioid Withdrawal Score &gt; 8 . A 0.03 mg dose also test . A 0.01 mg dose test 4 subject experience 1 bowel movement within 24 hour period post dose 0.03 mg dose cohort</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Understand sign inform consent form Males agree use approve doublebarrier method contraception Day 1 1 month study completion Subject test negative urine drug test unless subject prescription drug ( ) test positive Subjects opioid therapy cancerrelated pain management drug addiction Fecal incontinence , irritable bowel syndrome , inflammatory bowel disease , active medical disorder associate diarrhea , intermittent loose stool , constipation Subjects participate investigational drug study within 30 day prior Day 1 Prior exposure S297995</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Chronic pain</keyword>
	<keyword>Opioid physical dependence</keyword>
</DOC>